0001209191-22-021394.txt : 20220328 0001209191-22-021394.hdr.sgml : 20220328 20220328210328 ACCESSION NUMBER: 0001209191-22-021394 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220324 FILED AS OF DATE: 20220328 DATE AS OF CHANGE: 20220328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Anthony H. CENTRAL INDEX KEY: 0001759782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37939 FILM NUMBER: 22777161 MAIL ADDRESS: STREET 1: 5 WEST FORSYTH STREET STREET 2: SUITE 200 CITY: JACKSONVILLE STATE: FL ZIP: 32202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Marker Therapeutics, Inc. CENTRAL INDEX KEY: 0001094038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880277072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3200 SOUTHWEST FREEWAY STREET 2: SUITE 2500 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: (713) 400-6400 MAIL ADDRESS: STREET 1: 3200 SOUTHWEST FREEWAY STREET 2: SUITE 2500 CITY: HOUSTON STATE: TX ZIP: 77027 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC. DATE OF NAME CHANGE: 20170629 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC DATE OF NAME CHANGE: 20070628 FORMER COMPANY: FORMER CONFORMED NAME: GENEMAX CORP DATE OF NAME CHANGE: 20020718 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-24 0 0001094038 Marker Therapeutics, Inc. MRKR 0001759782 Kim Anthony H. C/O MARKER THERAPEUTICS, INC. 3200 SOUTHWEST FREEWAY, SUITE 2500 HOUSTON TX 0 1 0 0 Chief Financial Officer Common Stock 2022-03-24 4 A 0 150512 0.00 A 150512 D Common Stock 2022-03-24 4 F 0 36076 0.4848 D 114436 D Represents a restricted stock unit ("RSU") award. Represents shares withheld to satisfy tax obligations with respect to the vesting of the RSUs. /s/ Michael Loiacono, Attorney-in-Fact 2022-03-28